| 【Company Research】Samsonite (1910 HK) - Weak FY24 dragged by TUMI and American Tourister, 1Q25 sales to decline LSD-MSD |
| 【Company Research】InnoCare Pharma (9969 HK) - Orelabrutinib-led growth with strategic pipeline advancements in oncology and autoimmune |
| 【Company Research】Carote Ltd (2549 HK) - Still subject to numerous macro risks |
| 【Company Research】DPC Dash (1405 HK) - Long-term story intact but let’s just play safe |
| 【Company Research】Innovent Biologics (1801 HK) - Entering sustainable profitability with a global innovation engine |
| 【Company Research】EHang Holdings (EH US) - Obtained the first-ever OC for commercial operations |
| 【Company Research】GAC Group (2238 HK/601238 CH) - Can new management turn around homegrown brands? |
| 【Company Research】Great Wall Motor (2333 HK/601633 CH) - Wey could be key to FY25 earnings growth |
| 【Company Research】Sinotruk (Hong Kong) (3808 HK) - Stay cautious on exports |
| 【Company Research】Xunfei Healthcare (2506 HK) - Accelerated growth in 2H24 solidifies leadership in medical AI |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
